Quantum Innovators Network: Building the Future of Drug Discovery

Explore the intersection of AI, quantum technologies and medicinal chemistry at this in-person Quantum Innovators Network session in Haymarket. Dr Mark Waller, Founder and CEO of Sydney-based Pending AI, will discuss translating frontier research into commercial work in drug discovery.

What to expect

• A presentation and discussion with Dr Mark Waller
• Mark’s journey from academic researcher to deep-tech entrepreneur
• Perspectives on using AI and quantum mechanics in computational drug discovery
• Discussion of cross-disciplinary collaboration across computer science, chemistry, biology and quantum technologies
• A Q&A, followed by networking drinks and light refreshments

About the speaker

Dr Mark Waller has more than 15 years of experience across academia and industry. He leads Pending AI, which develops computational technologies intended to support the design and optimisation of small-molecule medicines.

Who it’s for

The Quantum Innovators Network series is for quantum enthusiasts and innovators. This session may also be relevant to researchers, students and aspiring entrepreneurs interested in taking breakthrough ideas beyond the lab.

Venue and access

The venue partner is Stone & Chalk. The event is at 477 Pitt Street, Haymarket, near Belmore Park and Sydney Central Station. All ages are welcome.

If you need accessibility accommodations, contact info.sqa@sydney.edu.au in advance.

Photography

By registering, you consent to photography and filming that may be used by the organisers in promotional materials, publications and online content.